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Introduction
Vascular remodeling is a critical part of the pathogenesis of 
clinically important vascular disorders such as atherosclerosis, 
restenosis after angioplasty, and saphenous vein graft disease 
(Shanahan and Weissberg, 1998; Owens et al., 2004). Despite 
considerable study, the molecular mechanisms that control 
vascular smooth muscle cell (VSMC) activities during vascu-
lar remodeling are not fully understood. Recent reports linking 
cadherins to VSMC regulation (Jones et al., 2002; Uglow et al., 
2003; Slater et al., 2004) suggest that these transmembrane 
adhesion proteins, characterized extensively as major media-
tors of epithelial cell homeostasis, may also be important in 
vascular remodeling.
Cadherins are involved in Ca
2+-dependent cell–cell ad-
hesion, intracellular junction assembly, and tissue morpho-
genesis during development (Yap et al., 1997; Angst et al., 
2001; Wheelock and Johnson, 2003b). Major subdivisions of 
the large cadherin superfamily include the classical cadherins 
and the protocadherins (Gallin, 1998; Yagi and Takeichi, 2000; 
Angst et al., 2001). The extracellular domains of these proteins 
share a unique structure, the cadherin motif, which is repeated 
in tandem in variable numbers. Classical cadherins function as 
homophilic adhesive molecules, and both extracellular and cyto-
plasmic domains contribute to this function. Classical cadherin 
cytoplasmic domains interact with β-catenin and plakoglobin 
(Takeichi, 1995; Huber and Weis, 2001), members of the arma-
dillo gene family of transcription factors. This interaction ef-
fectively sequesters β-catenin away from the nucleus, limits its 
transcriptional activity (Sadot et al., 1998; Kaplan et al., 2001; 
Simcha et al., 2001), and thus links cadherins to the canonical 
Wnt signaling pathway, a major determinant of cellular activity 
during development (Bhanot et al., 1999; Jamora et al., 2003; 
Nelson and Nusse, 2004).
We identifi  ed the protocadherin Fat1 in a screen for mole-
cules expressed differentially after balloon injury of rat carotid 
arteries. Like classical cadherins, protocadherins have extra-
cellular domains capable of Ca
2+-dependent, homophilic inter-
action (Suzuki, 2000). Protocadherin cytoplasmic domains, 
on the other hand, are structurally divergent from those of the 
classical cadherins, and less is known about their function. 
  Sequestration and inhibition of β-catenin by protocadherins has 
not been described.
Although mammalian Fat1 genes (Dunne et al., 1995; 
Ponassi et al., 1999; Cox et al., 2000) were initially character-
ized as homologues of the Drosophila protein Fat (Mahoney 
et al., 1991), recent bioinformatics analysis indicates that Fat1 
is more closely related to Drosophila Fat-like (Ftl) (Castillejo-
Lopez et al., 2004). In Drosophila, Ftl is expressed apically in 
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T
he signiﬁ   cance of cadherin superfamily proteins 
in vascular smooth muscle cell (VSMC) biology is 
undeﬁ  ned. Here we describe recent studies of the 
Fat1 protocadherin. Fat1 expression in VSMCs increases 
  signiﬁ  cantly after arterial injury or growth factor stimu-
lation. Fat1 knockdown decreases VSMC migration in 
  vitro, but surprisingly, enhances cyclin D1 expression 
and proliferation. Despite limited similarity to classical 
cadherins, the Fat1 intracellular domain (Fat1IC) interacts 
with  β-catenin, inhibiting both its nuclear localization 
and transcriptional activity. Fat1 undergoes cleavage 
and Fat1IC species localize to the nucleus; however, inhi-
bition of the cyclin D1 promoter by truncated Fat1IC pro-
teins corresponds to their presence outside the nucleus, 
which argues against repression of β-catenin–dependent 
transcription by nuclear Fat1IC. These ﬁ  ndings  extend 
  recent observations about Fat1 and migration in other 
cell types, and demonstrate for the ﬁ   rst time its anti-
  proliferative activity and interaction with β-catenin. Because 
it is induced after arterial injury, Fat1 may control VSMC 
functions central to vascular remodeling by facilitating 
migration and limiting proliferation.
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luminal tissues such as trachea, salivary glands, proventriculus, 
and hindgut (Castillejo-Lopez et al., 2004). Silencing of ftl re-
sults in the collapse of tracheal epithelia, and it has been sug-
gested that Ftl is required for morphogenesis and maintenance 
of tubular structures of ectodermal origin.
Like Drosophila Fat and Ftl, mammalian Fat1 is remark-
able for its very large size ( 4,600 aa). It has a huge extracellular 
domain that contains 34 cadherin repeats, 5 EGF-like repeats 
and l laminin A-G motif, a single transmembrane region, and 
a cytoplasmic tail of  400 aa (Dunne et al., 1995). Sequences 
within the Fat1 intracellular domain (Fat1IC) show limited 
 similarity  to  β-catenin binding regions of classical cadherins 
(Dunne et al., 1995).
Our studies show that Fat1 expression increases after in-
jury of the rat carotid artery, and is positively regulated in cul-
tured VSMCs by several factors that promote cell proliferation 
and migration. Interestingly, knockdown of Fat1 expression 
limits VSMC migration, but enhances VSMC growth. This anti-
proliferative effect of Fat1 appears to be mediated by Fat1IC 
  sequences because expression of a fusion protein containing the 
Fat1IC inhibits cyclin D1 expression and cell growth. Moreover, 
the Fat1IC can interact with β-catenin, prevent its nuclear trans-
location, and limit its transcriptional activity on both synthetic 
and native β-catenin–responsive promoters, including that of 
cyclin D1, a known target of canonical Wnt signaling. These 
fi  ndings point to an integrative role for Fat1 in regulation of 
critical VSMC activities in which it promotes migration and 
limits both canonical Wnt signaling and VSMC growth in the 
remodeling artery.
Results
Expression of Fat1 increases 
after arterial injury
We quantitated fat1 mRNA expression by quantitative PCR 
(qPCR) of cDNA samples from normal and injured rat carotid 
arteries. Compared with uninjured arteries, fat1 mRNA expres-
sion was  8.5-, 13.0-, and 3.9-fold higher than control at 3, 7, 
and 14 d after injury, respectively (Fig. 1 A).
To localize Fat1 protein expression in injured arteries, 
we characterized rabbit antisera raised against a GST-Fat1IC 
immunogen. Immunoblotting of VSMC lysates with one such 
antiserum, but not preimmune serum, yielded a single high 
molecular weight band of  500 kD, in accord with the pre-
dicted size of full-length Fat1 (Fig. 1 B). Further specifi  city 
was demonstrated in RNAi experiments directed against mul-
tiple separate targets in the mouse Fat1 sequence (see Figs. 3 
and 4). We then used the antiserum for immunohistochemical 
studies. As shown in Fig. 1 C, prominent Fat1 staining ap-
peared in the media 3 d after injury, while at 7 and 14 d after 
injury Fat1 staining was less evident in the media, but clearly 
present in the developing neointima. Western analysis of Fat1 
Figure 1.  Expression of Fat1 in normal and balloon-
injured rat carotid arteries. (A) qPCR analysis of fat1 
mRNA expression. Fat1 mRNA levels were corrected 
relative to gapdh mRNA levels, with day 0 (no injury) 
set = 1. *, P < 0.05, **, P < 0.01 vs. day 0. Data 
show the means ± SEM. (B) speciﬁ   city of anti-Fat1 
  antiserum. Preimmune and anti-Fat1 immune rabbit sera 
(1:5,000 dilutions) were tested by immunoblotting of 
replicate total RASMC protein extracts (20 μg/lane). 
Arrow indicates Fat1 signal. (C) Immunohistochemical 
analysis of Fat1 expression in arteries 0, 3, 7, and 
14 d after injury, as indicated. Fat1 immunoreactivity 
appears brown, with blue hematoxylin counterstain 
except in top right panel. Arrowheads indicate the 
  internal elastic lamina, and double-ended arrows, the 
extent of the media. The neointima is the space 
  between arrowhead and arrow. The orientation of all 
samples is similar, with an asterisk in the day 0 panel 
indicating the vessel lumen. The top right panel shows 
a day 7 sample costained for Fat1 (brown) and PCNA 
(blue); areas of increased Fat1 (arrow) and increased 
PCNA (arrowhead) staining are indicated. The bottom 
right panel shows a day 7 sample in which Fat1 anti-
serum was omitted (no 1° ab). Scale bar, 100 μm.FAT1 AND VASCULAR REMODELING • HOU ET AL. 419
expression in the carotid artery injury model, like our qPCR 
fi  ndings, showed a clear induction after injury (unpublished 
data). To correlate Fat1 expression with the proliferative status 
of specifi  c cells, we co-stained sections for Fat1 and the prolif-
eration marker PCNA. Although some cells appeared positive 
for both, we also noted some spatial separation of the signals, 
particularly evident in areas with limited neointimal forma-
tion, which showed prominent Fat1 staining without PCNA 
(Fig. 1 C, top right). The latter observation raised the possi-
bility that, despite its overall induction after injury, increased 
Fat1 expression might have negative effects on VSMC growth 
in vivo.
Serum and growth factors induce Fat1 
expression in VSMCs
To identify factors that might contribute to Fat1 induction after 
arterial injury, we characterized its expression in primary 
  cultured VSMCs. Quiescent rat aortic smooth muscle cells 
(RASMCs) (time 0 h) were treated with 10% FBS for 2, 6, 12, 
18, 24, and 36 h, and the level of Fat1 protein was determined 
by Western analysis. The Fat1 signal increased strongly between 
2 and 12 h and remained elevated through 36 h (Fig. 2 A). 
To assess cell cycle status, we also checked cyclin D1 expression 
in these lysates. Interestingly, Fat1 induction preceded the 
  increase of cyclin D1, a mediator of progression through the G1 
phase of the cell cycle (Fig. 2 A).
We then assessed Fat1 expression in response to several 
factors known to affect the vascular response to injury. Western 
analyses showed that expression of Fat1 increased in response 
to Angiotensin II (ATII), basic FGF (bFGF), and PDGF-BB 
(Fig. 2 B). Increased Fat1 expression was apparent by 2 h and 
sustained at high levels from 12 to 36 h after stimulation with 
each of these factors. Thus, Fat1 expression is regulated consis-
tently and strongly by multiple factors known to promote VSMC 
growth and migration.
Inhibition of Fat1 expression limits 
VSMC migration
Two recent studies have described a role for Fat1 in regulation 
of epithelial cytoskeletal actin dynamics, planar polarity, and 
migration, mediated through interactions of the Fat1 cyto-
plasmic domain with proteins of the Ena/VASP family (Moeller 
et al., 2004; Tanoue and Takeichi, 2004). Fat1 induction by 
known VSMC chemotactic factors (Fig. 2) suggested that Fat1 
might also be involved in VSMC migration. To test this and 
other potential Fat1 functions, we developed reagents to effec-
tively manipulate Fat1 expression. Transfection of mouse aor-
tic smooth muscle cells (MASMCs) with Fat1 specifi  c small 
interfering RNAs (siRNAs), but not scrambled or mismatch 
derivatives, resulted in signifi  cantly decreased levels of Fat1 
protein (Fig. 3 A). To isolate and augment signals mediated by 
the Fat1IC, we generated a cDNA construct, IL2R-Fat1IC, in 
which the entire Fat1 cytoplasmic domain was fused to the ex-
tracellular domain and transmembrane region of the interleu-
kin 2 receptor α-chain (IL2R), with or without a COOH-terminal 
FLAG epitope tag (Fig. 3 B). Subcellular localization of this 
fusion protein was tested in 3T3 cells, which do not express 
detectable Fat1, and A7r5 VSMCs, which express moderate 
amounts of endogenous Fat1; both transfected 3T3 and A7r5 
cells showed an appropriate cell surface signal when stained 
with anti-FLAG epitope antibody (Fig. 3 B and unpublished 
data). Cell migration in monolayers treated with specifi  c Fat1 
siRNA was modestly but signifi  cantly decreased compared 
with control siRNA (Fig. 3 C), which indicates that Fat1 
  expression is required for optimal VSMC migration. Surpris-
ingly, we also found decreased migration of VSMCs express-
ing the IL2R-Fat1IC protein in a Transwell assay using FBS as 
a stimulant in the lower chamber (Fig. 3 D). We confi  rmed 
both expression of Ena/VASP proteins in VSMCs and the abil-
ity of the IL2R-Fat1IC protein to interact with these signaling 
intermediates (unpublished data). We surmise that although 
the IL2R-Fat1IC construct may increase intracellular Fat1 sig-
naling, it also dissociates Fat1 extracellular interactions from 
this intracellular signaling, and thus interferes with directional 
  migration. Altogether, these fi  ndings indicate that Fat1 promotes 
VSMC migration; it is likely that, as described in epithelial 
cells, interactions with Ena/VASP proteins link Fat1 expres-
sion to VSMC cytoskeletal actin reorganization, polarization, 
and migration.
Figure 2.  Western analysis of Fat1 expression in RASMCs. Cells were serum 
deprived, stimulated as described, and harvested for protein   extraction at 
the indicated time points. Actin expression is shown as a loading reference. 
Data are representative of three independent   experiments. (A) Induction by 
10% FBS for 0–36 h before protein extraction. The blot was also probed 
for cyclin D1. (B) Induction by speciﬁ   c factors. Cells were stimulated 
with 10
−6 mol/L ATII, 20 ng/ml bFGF, or 20 ng/ml PDGF-BB.JCB • VOLUME 173 • NUMBER 3 • 2006  420
Inhibition of Fat1 expression promotes 
VSMC growth
In addition to increased migration, the VSMC response to 
injury is characterized by cell cycle entry and increased prolif-
eration (Clowes et al., 1983a). To evaluate how Fat1 induction 
after injury might affect VSMC growth, we tested the effect of 
Fat1 knockdown on expression of cyclin D1, a marker of cell 
cycle activation. Four distinct mouse Fat1 siRNA duplexes 
  attenuated endogenous Fat1 levels in MASMCs; with each 
  duplex, we also observed a signifi  cant increase in cyclin D1 
  expression over control levels (Fig. 4 A and unpublished). 
The similarity of effect achieved by multiple distinct siRNAs 
argues strongly that increased cyclin D1 expression results from 
decreased Fat1, and not an off-target effect. The duration of 
Fat1 inhibition was more than 90% at 2 and 3 d after transfection, 
with persistent and strong inhibition still apparent after 6 d 
(Fig. 4 B). Decreased Fat1 expression corresponded to increased 
cyclin D1 signal at each time point (2.0–2.5-fold increase of 
  cyclin D1/actin ratio vs. control), suggesting that endogenous 
Fat1 exerts a tonic inhibitory effect on cyclin D1 expression 
(Fig. 4 B). The level of total β-catenin in these cells, by contrast, 
showed little change.
We then examined the effect of Fat1 knockdown on DNA 
synthesis. Cells were transfected with Fat1 or control siRNA, 
and then were serum deprived for 48 h before stimulation with 
10% FBS and evaluation of BrdU incorporation. In Fat1 knock-
down cultures, the fraction of BrdU-positive cells was signifi  -
cantly higher than in control siRNA cells (52 ± 7% vs. 30 ± 8%, 
P < 0.05) (Fig. 4 C). These fi  ndings indicate that decreased 
Fat1 expression promotes cell cycle progression and DNA syn-
thesis in VSMCs.
The Fat1IC is sufﬁ  cient to inhibit 
VSMC growth
Classical cadherins interact with intracellular signaling path-
ways through their cytoplasmic domains (Wheelock and Johnson, 
2003a). To establish cell populations differing primarily in their 
expression of the Fat1IC, we transferred the IL2R (without cyto-
plasmic domain) and IL2R-Fat1IC constructs into the GFP-
RV retroviral vector (Ranganath et al., 1998), produced viral 
supernatants, and transduced A7r5 and primary MASMCs. 
Additional control cells, denoted RV, were produced using the 
unmodifi  ed GFP-RV vector. Western analysis confi  rmed IL2R-
Fat1IC expression in A7r5 and MASMCs (Fig. 5 A). Interest-
ingly, endogenous cyclin D1 levels were lower in both A7r5 
and MASMCs expressing IL2R-Fat1IC (Fig. 5 A). In cell growth 
assays over 7 d, A7r5 cells expressing IL2R showed no signif-
icant change from control RV cells, but decreased cell num-
bers were evident in the IL2R-Fat1IC at all time points after 3 d 
(Fig. 5 B). In addition, both A7r5 and MASMCs expressing the 
IL2R-Fat1IC construct showed signifi  cantly lower fractions of 
BrdU-positive nuclei, indicating that this decrease in cell num-
ber refl  ected growth inhibition rather than decreased survival 
(Fig. 5 C).
Fat1 and 𝗃-catenin colocalize and interact 
in VSMCs
In epithelial cells, classical cadherins such as E-cadherin 
  regulate Wnt signaling activity by physically associating with 
β-catenin at points of cell–cell contact (Nathke et al., 1994). 
The sequences, interacting proteins, and functions of protocad-
herin cytoplasmic domains are typically thought to be divergent 
Figure 3.  Effect of decreased Fat1 expression on VSMC migration. 
(A) Western analysis of Fat1 speciﬁ  c and control siRNA efﬁ  cacy, 48 h after 
transfection. (B) Schematic diagram of IL2R-Fat1IC. EC, extracellular; TM, 
transmembrane; IC, intracellular, with photomicrograph of subcellular 
  localization of IL2R-Fat1IC-3XFLAG in transfected cells stained with FITC-
conjugated anti-FLAG antibody. Arrowheads indicate cell surface staining. 
(C) MASMC migration 30 h after wounding of monolayer. Dashed lines in-
dicate extent of initial denudation. Bottom, quantitative analysis of MASMC 
migration after control (Ctl) and speciﬁ  c Fat1 siRNA transfection. For 10 
matched ﬁ  elds, the area of the wounded monolayer covered by cells at the 
indicated time points was determined by planimetry using NIH Image, and 
distance migrated calculated according to the difference from time 0. 
*, P < 0.05 vs. Ctl siRNA. (D) Transwell migration assay of A7r5 cells 
transduced with the indicated retroviruses. Six ﬁ   elds were counted per 
  condition, and the values were averaged for each ﬁ  lter. Data show the 
means ± SEM. *, P < 0.05 vs. other groups.FAT1 AND VASCULAR REMODELING • HOU ET AL. 421
from those of the classical cadherins (Yagi and Takeichi, 2000), 
and Fat1 is not regarded as part of the classical cadherin system 
(Tanoue and Takeichi, 2005). Nevertheless, we found that the 
Fat1IC has growth inhibitory activity, and that expression of  cyclin 
D1, a known target of the canonical Wnt signaling pathway, corre-
lated negatively with Fat1IC expression. Together, these fi  ndings 
suggested that growth inhibition by Fat1 might involve β-catenin. 
In our immunofl  uorescent analyses of RASMCs (Fig. 6), Fat1 
localized to both cell–cell junctions and cellular free edges, 
while β-catenin was concentrated at sites of cell–cell contact. 
By two color immunofl  uorescence analysis, we found areas 
along cell–cell junctions where the two signals overlapped (Fig. 
6 A). This overlap did not include the cellular free edges, where 
Fat1 alone was seen (Fig. 6 B).
Junctional β-catenin and Fat1 have been identifi  ed in epi-
thelial cells that display apical–basal polarity, but it is thought 
that the two proteins occupy distinct domains, with β-catenin at 
Figure 4.  Effect of decreased Fat1 expression on VSMC cell cycle progression. 
(A and B) Western analyses of Fat1 and cyclin D1 expression with control 
(Ctl) or Fat1-speciﬁ  c siRNAs. (A) Four distinct Fat1-speciﬁ  c siRNAs were 
transfected 48 h before protein extraction. Loading reference, α-tubulin. 
(B) Efﬁ   cacy of Ctl or Fat1-speciﬁ   c siRNA 7296 over time. Actin and 
β-catenin expression were also tested. (C) Effect of Fat1 inhibition on DNA 
synthesis assessed by BrdU incorporation. Cells were transfected with Ctl 
or Fat1 siRNA, serum deprived for 48 h, and stimulated with 10% FBS. 
BrdU incorporation was assessed as described in Materials and methods. 
The graph depicts the means ± SEM of three independent experiments in 
which a total of 219–874 cells were counted each time for each group. 
*, P < 0.05 vs. Ctl siRNA.
Figure 5.  Effect of IL2R-Fat1IC expression on VSMC growth. RV, IL2R, and 
IL2R-Fat1IC designate A7r5 or MASMCs transduced with the corresponding 
retroviral constructs. (A) Western analyses of IL2R-Fat1IC expression in A7r5 
and MASMC stable transfectants. A nonspeciﬁ   c band (ns) near the 
IL2R-Fat1IC protein is indicated. The blots were also probed for cyclin D1 and 
actin. (B) Effect of IL2R-Fat1IC on A7r5 cell growth. Cell number was calculated 
by CyQuant ﬂ  uorescence assay by reference to a standard curve. (C) Effect 
of IL2R-Fat1IC on DNA synthesis in A7r5 and MASMCs, evaluated by BrdU 
incorporation. Data show the means ± SEM. *, P < 0.05 vs. control.JCB • VOLUME 173 • NUMBER 3 • 2006  422
apical adherens junctions and Fat1 at basolateral points of cell–
cell contact (Tanoue and Takeichi, 2004, 2005). VSMCs are 
nonpolarized (Muller and Gimbrone, 1986), so this model of 
apical–basal domain specialization may not apply. To test di-
rectly if Fat1 and β-catenin can interact at physiologic levels of 
expression in VSMCs, we immunoprecipitated endogenous Fat1 
and tested for recovery of β-catenin. Both this assay and recip-
rocal coimmunoprecipitations of β-catenin followed by immuno-
blotting for Fat1 demonstrated interaction of the two proteins 
(Fig. 6 C). This fi  nding suggests that the nonpolarized nature of 
VSMCs allows for protein–protein interactions not found in 
  polarized cell types such as epithelial cells. Further immuno-
blotting of Fat1 immunoprecipitates with a pan-cadherin antibody 
did not reveal associated (classical) cadherins that might asso-
ciate with both Fat1 and β-catenin (unpublished data).
To characterize the Fat1–β-catenin interaction further, we 
used coimmunoprecipitation assays in cotransfected 293T cells 
to map the sequences required for interaction. We generated a 
series of constructs bearing deletions within the Fat1IC portion 
of the IL2R-Fat1IC-3XFLAG (Fig. 7 A). IL2R-E-cadherinIC-
3XFLAG and IL2R-3XFLAG (containing no Fat1 sequences) 
constructs served as positive and negative controls, respectively. 
We confi   rmed the expression of Myc-tagged β-catenin and 
FLAG-tagged fusion proteins, and immunoprecipitation of 
transfected Myc-tagged β-catenin (Fig. 7 B, bottom panels). 
 Interaction  of  β-catenin with the IL2R-Fat1IC-3XFLAG deriva-
tives was assessed by immunoblotting with FLAG antibody 
(Fig. 7 B, top). A robust FLAG signal was obtained with the 
IL2R-Fat1IC-3XFLAG construct containing the complete Fat1IC 
domain and with derivatives I, III, and V. Weaker signals were 
seen with constructs II and IV, which lack the FC1 and both 
FC1 and FC2 domains, respectively. Although these fi  ndings 
based on overexpressed proteins must be interpreted with cau-
tion, they suggest that β-catenin interacts with the Fat1IC princi-
pally through the FC1 domain, but leave open the possibility 
that the FC2 domain or additional sequences also contribute to 
the interaction. Interestingly, the E-cadherin–based positive 
control yielded a comparatively strong band, despite input of 
substantially less protein.
Expression of the Fat1IC affects 
𝗃-catenin cellular distribution 
and transcriptional activity
Thus, changes in Fat1 or Fat1IC expression affected expression 
of a β-catenin target gene, cyclin D1, but had little effect on 
overall β-catenin levels (Figs. 4 and 5). Having found evidence 
for colocalization and interaction of β-catenin and Fat1 in 
VSMCs, we postulated that Fat1 might be acting like a classical 
cadherin to affect the subcellular localization and activity of 
β-catenin. We examined this fi  rst using immunocytochemistry. 
Expression plasmids encoding IL2R or IL2R-Fat1IC were intro-
duced into VSMCs, which were subsequently treated with 
20 mM LiCl for 6 h to activate Wnt signaling and promote nuclear 
translocation of β-catenin (Hedgepeth et al., 1997). The inten-
sity of nuclear β-catenin staining did not appear to be affected 
by expression of IL2R (Fig. 8 A, top, arrows). In contrast, nu-
clear accumulation of β-catenin appeared decreased in the 
IL2R-Fat1IC–expressing cells (Fig. 8 A, bottom, arrows) as 
compared with untransfected cells. To assess this effect in a 
more quantitative way, we determined the distribution of 
β-catenin in the membrane, cytoplasmic, and nuclear fractions of 
IL2R-GFP-RV– and IL2R-Fat1IC-GFP-RV–transduced VSMC 
cultures treated with LiCl. As shown in Fig. 8 B, immuno-
blotting showed a relative decrease in nuclear β-catenin accu-
mulation in cells expressing IL2R-Fat1IC as compared with 
those expressing IL2R (respective nuclear β-catenin/lamin A/C 
ratios 0.8 [IL2R-Fat1IC] vs. 1.65 [IL2R]).
Figure 6.  Co-localization and interaction of endogenous 𝗃-catenin and 
Fat1 in VSMCs. (A) Immunoﬂ  uorescence analysis of β-catenin (β-cat, red), 
Fat1 (green), and areas of colocalization (merge, yellow). Nuclei were 
stained with DAPI (blue), as indicated. β-Catenin and Fat1 colocalization 
at cell–cell junctions is indicated by an arrowhead. Bar (10 μm) applies to 
all panels. (B) Detail from panels in A, showing staining for Fat1 (green), 
but not β-catenin (red), at the cellular free edge. Bar, 10 μm. (C) Co-immuno-
precipitation of endogenous β-catenin and Fat1. Cell lysates were incu-
bated with antibodies speciﬁ  c for Fat1 (top) or β-catenin (bottom) or normal 
rabbit or mouse IgG, and the immunoprecipitated complexes were ana-
lyzed by Western blot for Fat1 and β-catenin, as indicated.FAT1 AND VASCULAR REMODELING • HOU ET AL. 423
To assess further the functional signifi  cance of the Fat1–
β-catenin interaction in VSMCs, we tested the effect of Fat1IC 
overexpression on β-catenin–mediated transcription. A7r5 cells 
were cotransfected with β-catenin and/or IL2R-Fat1IC, along 
with the TCF-luciferase reporter construct Topfl   ash or its 
  negative control, Fopfl  ash (Fig. 9 A). Topfl  ash reporter activity 
refl   ects activation of the canonical Wnt signaling pathway, 
β-catenin nuclear translocation, and formation of TCF/β-catenin 
heterodimers; Fopfl  ash contains mutated TCF binding sites and 
serves as a control for nonspecifi  c activation (Korinek et al., 1997). 
A full-length N-cadherin cDNA and the IL2R–E-cadherinIC 
construct were also tested as controls. Specifi  c activation of 
Topfl  ash by β-catenin was  10-fold above basal levels, and 
the three test constructs all inhibited this activation signifi  cantly. 
Interestingly, the inhibition due to both IL2R-Fat1IC (40%) and 
N-cadherin (55%) was less complete than that resulting from 
cotransfection of IL2R-E-cadherinIC, which abolished all 
β-catenin–mediated transactivation. We also evaluated the effect 
of decreased Fat1 expression. Immunocytochemistry of LiCl-
stimulated MASMCs suggested a relative enhancement of 
 nuclear  β-catenin staining in Fat1-depleted cells (Fig. 9 B). 
To assess this observation more quantitatively, we transfected 
MASMCs fi  rst with control or Fat1-specifi  c siRNA, and then with 
the Topfl  ash reporter. As shown in Fig. 9 C, LiCl-stimulated 
TCF/β-catenin transcriptional activation was  30% higher 
in Fat1 knockdown cells compared with control.
As shown in Figs. 4 and 5, cyclin D1 levels varied in-
versely with the level of Fat1IC expression. The cyclin D1 pro-
moter is a known transcriptional target of Wnt signaling and 
activated TCF/β-catenin complexes (Shtutman et al., 1999; 
Tetsu and McCormick, 1999), so we postulated that Fat1IC 
might also inhibit the native cyclin D1 promoter. VSMCs were 
cotransfected with β-catenin and/or IL2R-Fat1IC, along with the 
cyclin D1 promoter–luciferase reporter construct (Herber et al., 
1994). N-cadherin and the IL2R–E-cadherinIC fusion protein 
were also tested. Most of the β-catenin–mediated activation of 
the cyclin D1 promoter reporter was eliminated by IL2R-Fat1IC 
or N-cadherin expression (Fig. 9 D). Consistent with the Top-
fl   ash results, IL2R–E-cadherinIC was more effective, as it 
  decreased promoter activity to a level below baseline.
Figure 7. Identiﬁ  cation of 𝗃-catenin-interacting residues in 
the Fat1IC domain by coimmunoprecipitation of epitope-
tagged proteins. (A) Schematic depiction of FLAG-tagged 
IL2R-Fat1IC deletion constructs. Fat1IC domains indicated: 
  juxtamembrane (JM), FC1, FC2, carboxy-terminus (CT). 
(B) Western analysis of immunoprecipitated protein complexes. 
The indicated constructs were transfected into 293T cells. Top: 
after 24 h, total cellular protein (400 μg) was harvested and 
analyzed by immunoprecipitation and Western blotting (WB) 
with antibodies against the epitope tags, as indicated.   Bottom: 
protein input (7.5%). An analogous E-cadherin–derived 
  construct (IL2R-E-cadIC-FLAG) was used as a positive control.JCB • VOLUME 173 • NUMBER 3 • 2006  424
Inhibition of 𝗃-catenin activity depends 
on extranuclear localization of the Fat1IC
Fat1 is a type I transmembrane protein, and immunofl  uorescent 
studies with antiserum specifi  c for Fat1IC sequences showed ex-
pression at the cell surface, as expected (Fig. 6). We also noted 
consistent signals in the cell nucleus with this antiserum. This 
observation, together with a recent report of localization of Fat1 
cytoplasmic sequences to the nucleus (Magg et al., 2005), raised 
the possibility that inhibition of β-catenin by Fat1 might result 
from a nuclear (transcriptional repressor) function of a cleaved 
Fat1IC fragment, rather than sequestration of β-catenin outside 
the nucleus. Indeed, incubation without proteinase inhibitors of 
extracts of A7r5 cells expressing both native Fat1 and the IL2R-
Fat1IC fusion protein showed the disappearance of these full-
length proteins and rapid appearance of a single, relatively 
stable species of  50 kD (Fig. 10 A). Because the NH2 termi-
nus of this cleaved product is not yet defi  ned, we designate it as 
Fat1IC*; its apparent size in SDS-PAGE suggests that it contains 
most (if not all) of the  400 aa Fat1IC domain.
Like human Fat1IC (Magg et al., 2005), the mouse Fat1IC 
contains a potential NLS (R K M I S R K K K R ) near its NH2 terminus. 
We tested the effect of this sequence on Fat1IC localization 
by immunocytochemical analysis of A7r5 cells transfected with 
FLAG-tagged expression constructs that retain (Fat14189–4587) or 
exclude (Fat14201–4587) the NLS motif. Fat14189–4587 localized almost 
exclusively to the nucleus, whereas Fat14201–4587 was apparent in 
the nucleus and prominent throughout the cytoplasm (Fig. 10 B).
To evaluate these fi  ndings in the context of Fat1-mediated 
VSMC growth inhibition, we tested these Fat1IC derivatives for 
effects on cyclin D1 promoter activity. The IL2R-Fat1IC fusion 
protein yielded signifi   cant inhibition of β-catenin–mediated 
  cyclin D1 promoter activation (Fig. 9 D); Fat14201–4587, but not 
Fat14189–4587, retained this inhibitory effect (Fig. 10 C). Both 
Fat14201–4587 and Fat14189–4587 are present in the nucleus, but the 
former has a cytoplasmic distribution not shared by Fat14189–4587; 
hence, we attribute this inhibitory effect on β-catenin to the 
  extranuclear presence of Fat14201–4587.
Discussion
Fat1 is expressed widely during mouse and rat development 
(Ponassi et al., 1999; Cox et al., 2000), notably in areas with high 
levels of cellular proliferation. Although in situ hybridization of 
rat embryos demonstrated expression of fat1 mRNA in the devel-
oping aortic outfl  ow tract (Ponassi et al., 1999), the signifi  cance 
of Fat1 in vascular tissues has not been previously explored.
We found relatively low expression of Fat1 in normal 
adult rat carotid arteries, and substantially increased levels dur-
ing the fi  rst few days after injury (Fig. 1). Immunohistochemical 
analyses (Fig. 1 C) showed prominent Fat1 staining fi  rst in 
the injured arterial media, and subsequently in the neointima, 
a pattern of expression similar to that of VSMC proliferation in 
this model (Clowes et al., 1983b). Interestingly, areas of attenu-
ated neointimal formation showed prominent Fat1 and de-
creased PCNA staining, providing an initial suggestion that 
Fat1 might act to limit VSMC proliferation in vivo (Fig. 1 C). 
Nevertheless, Fat1 levels in cultured VSMCs increased in re-
sponse to serum and several factors known to promote VSMC 
activation and neointimal formation, including ATII (Powell 
et al., 1990), PDGF-BB (Ferns et al., 1991), and bFGF (Lindner 
and Reidy, 1991) (Fig. 2). This expression pattern contrasts 
with that described for N-cadherin, which decreases after stim-
ulation of VSMC with serum or PDGF-BB (Uglow et al., 2003), 
and that of R-cadherin, which decreases substantially in the fi  rst 
few days after injury (Slater et al., 2004).
To evaluate how induction of this very large protocad-
herin might affect the response to vascular injury, we tested 
the effect of Fat1 on VSMC migration and proliferation, two 
of the key cellular functions activated in this setting. Both loss 
of Fat1 expression and expression of the IL2R-Fat1IC fusion 
protein attenuated VSMC migration (Fig. 3). In the context 
of recent reports regarding Fat1 function in epithelial cells 
(Moeller et al., 2004; Tanoue and Takeichi, 2004), these fi  nd-
ings suggest that increased Fat1 expression facilitates VSMC 
migration by providing directional cues and stimulating actin 
cytoskeletal remodeling through its interactions with proteins 
of the Ena/VASP family. Together with the Fat1 knockdown 
results, inhibition of migration by the IL2R-Fat1IC fusion pro-
tein suggests that dissociation of Fat1 extracellular interactions 
from Fat1IC-mediated intracellular signaling interferes with 
 directional  migration.
Despite the induction of Fat1 in the proliferative phase 
  after injury and in response to growth factor stimulation of 
  cultured cells, our results in both loss- and gain-of-function 
Figure 8.  Effect of Fat1IC overexpression on 𝗃-catenin nuclear localization 
in VSMCs. (A) Immunoﬂ  uorescence analysis of β-catenin subcellular local-
ization in IL2R-GFP-RV (top) and IL2R-Fat1IC-GFP-RV (bottom) transduced 
RASMCs. Cells were treated with LiCl (20 mmol/L) for 6 h, and then 
stained with anti-β-catenin antibody and DAPI. Transduced cells were iden-
tiﬁ  ed by coexpressed GFP. Arrows indicate nuclear β-catenin signal of un-
transduced and transduced cells within each panel (see text). Bar, 10 μm. 
(B) Western analysis of β-catenin in membrane (M), cytoplasmic (C), and 
nuclear (N) fractions extracted from IL2R-GFP-RV and IL2R-Fat1IC-GFP-RV 
transduced A7r5 cells treated with LiCl, as above. The blot was probed for 
lamin A/C to assess fractionation and loading.FAT1 AND VASCULAR REMODELING • HOU ET AL. 425
studies (Figs. 4 and 5) suggest that Fat1 opposes VSMC prolif-
eration. Loss of growth suppression resulting in imaginal disc 
overgrowth in Drosophila led to identifi  cation of Fat (Mahoney 
et al., 1991), the founding member of the cadherin subfamily 
that includes mammalian Fat1. Although recent analyses indi-
cate that mammalian Fat1 is more closely related to Drosophila 
Ftl (Castillejo-Lopez et al., 2004) than to Fat, a growth regula-
tory function has yet to be described for Ftl. Altered growth 
characteristics were also not identifi  ed in mouse Fat1−/− neu-
ral progenitors and embryonic skin (Ciani et al., 2003). Thus, 
our fi  ndings in VSMCs may refl  ect cell type–specifi  c differ-
ences in the expression of cadherins or other protocadherins 
functionally redundant with Fat1, or differences in the level of 
β-catenin expression. In either case, the results of Fat1 knock-
down studies indicate that in VSMCs, endogenous levels of Fat1 
expression are suffi  cient to limit cyclin D1 expression (Fig. 4) 
and  β-catenin–mediated transcription (Fig. 9), whereas our 
gain-of-function studies (Fig. 5) suggest that decreased cyclin 
D1 expression and cell growth are likely physiologic conse-
quences of Fat1 induction. Cyclin D1, a known TCF/β-catenin 
target gene (Shtutman et al., 1999; Tetsu and McCormick, 
1999), plays a critical role in regulation of G1 phase progres-
sion and G1/S cell cycle transition (Jiang et al., 1993; Resnitzky 
et al., 1994), and the level of its expression is closely controlled. 
Increased Fat1 expression in response to injury probably acts to 
slow VSMC proliferation, at least in part by decreasing cyclin 
D1 expression.
Signaling by classical cadherins has been studied exten-
sively, but the mechanisms of protocadherin signaling are not 
well understood. The intracellular portion of Fat1 shows limited 
similarity to classical cadherin cytoplasmic domains, with 30 of 
137 (22%) residues matching consensus in the FC1 domain 
and 28 of 84 (33%) residues matching consensus in the FC2 
domain (Dunne et al., 1995). Although Tanoue and Takeichi 
  described partial colocalization of Fat1 and β-catenin in immor-
talized epithelial cell lines, they found more β-catenin in apical 
lateral cell contacts and more Fat1 in basal lateral cell contacts 
(Tanoue and Takeichi, 2004), and concluded that Fat1 does not 
Figure 9.  Effect of altered Fat1 expression on 
𝗃-catenin transcriptional activity in VSMCs. 
(A) Topﬂ   ash (TCF-luciferase reporter) activa-
tion. Topﬂ   ash or Fopﬂ   ash control was trans-
fected into A7r5 cells along with expression 
constructs for β-catenin, IL2R-Fat1IC, N-cadherin, 
and/or IL2R-E-cadherinIC. The maximal re-
porter activity was set to 100. *, P < 0.05, 
**, P < 0.01, vs. activity with β-catenin 
alone. (B) β-Catenin localization in MASMCs 
transfected with control (Ctl, scrambled) or 
Fat1-speciﬁ   c (7296) siRNAs and stimulated 
with LiCl (20 mM) for 12 h. (C) Topﬂ  ash activ-
ity with decreased Fat1 expression. MASMCs 
transfected with the indicated siRNAs and the 
Topﬂ   ash reporter were stimulated with LiCl 
(20 mM) for 12 h before assay for luciferase 
activity. *, P < 0.05, vs. activity with Ctl 
siRNA. (D) Cyclin D1 promoter activation. 
The  cyclin D1 promoter-luciferase construct 
was transfected into A7r5 cells along with test 
constructs, as in A. Data show the means ± SEM. 
*, P < 0.05, **, P < 0.01, vs. activity with 
β-catenin alone.JCB • VOLUME 173 • NUMBER 3 • 2006  426
participate in the classical cadherin system (Tanoue and 
Takeichi, 2005). Interestingly, these fi  ndings are consistent with 
the observation that in polarized epithelial cells, complexes 
forming between adjacent cells vary in composition according 
to their apical vs. basal position (Johnston and Gallant, 2002). 
Thus, our fi  ndings in VSMCs, which are morphologically and 
biochemically nonpolarized (Muller and Gimbrone, 1986), may 
differ because of the lack of apical–basal specialization in this 
cell type. In immunocytochemical studies, we found that 
β-catenin and Fat1 colocalized in a junctional pattern at points 
of contact between VSMCs (Fig. 6); Fat1 staining was also 
  observed at cellular free edges, while β-catenin was not.
To our knowledge, a physical interaction between endog-
enous Fat1 and β-catenin has not been previously demonstrated. 
We found clear evidence that these proteins interact at physio-
logic levels of expression. Transfection studies with the IL2R-
Fat1IC fusion protein indicated that, despite limited similarity 
to the β-catenin–interacting domains of classical cadherins, 
the Fat1IC domain was suffi  cient for this interaction (Fig. 7). 
Although mapping studies suggested that the Fat1 FC1 domain 
was most important for the β-catenin–Fat1 interaction, deletion 
of other domains within the Fat1IC also decreased the amount of 
protein coimmunoprecipitation, indicating that sequences both 
within and outside of the relatively conserved FC1 and FC2 
  domains may contribute to β-catenin–Fat1 interaction. Interest-
ingly, the FC1 domain corresponds to the area of greatest 
similarity (54/196 aa identity [27%]) with the Drosophila Ftl 
cytoplasmic domain; its role in the β-catenin–Fat1 interaction 
described here suggests that Ftl may be capable of interaction 
with armadillo, the Drosophila homologue of β-catenin.
The IL2R-Fat1IC chimera allowed us to perform func-
tional analyses without confounding effects attributable to in-
creased expression of the Fat1 extracellular domain. Expression 
of IL2R-Fat1IC, but not a control protein lacking the Fat1IC do-
main, decreased nuclear translocation of β-catenin (Fig. 8), and 
inhibited β-catenin transactivation of both synthetic (Topfl  ash) 
and native (cyclin D1) TCF-dependent promoters (Fig. 9). 
  Although we found evidence of Fat1 cleavage resulting in a 
Fat1IC* fragment that may localize to the nucleus (Fig. 10), only 
a defi  ned Fat1IC fragment lacking the NLS (aa 4189–4198) 
  reproduced the inhibitory effect of the IL2R-Fat1IC fusion 
  protein. This result suggests that inhibition of β-catenin transcri-
ptional activity is mediated by Fat1IC outside the nucleus, and 
is not due to Fat1IC peptides in the nucleus. Thus, it remains to 
be determined if cleavage and nuclear translocation of Fat1IC 
  underlies a specifi  c function, perhaps as a chaperone or tran-
scriptional regulator, or if it is important as a means to inactivate 
Fat1-mediated inhibition of β-catenin. Our studies to date 
  suggest that the interaction of Fat1 cytoplasmic sequences with 
β-catenin has consequences for overall regulation of VSMC 
growth. The underlying mechanism appears similar to that 
  described for classical cadherin-mediated sequestration of 
β-catenin in epithelial cells (Orsulic et al., 1999), but in the case 
of the protocadherin Fat1, this mechanism may be operative 
only in nonpolarized cells such as VSMCs.
Our fi  ndings suggest that increased expression of Fat1 
  after vascular injury facilitates migration and opposes prolif-
eration of VSMCs. The former effect likely involves Fat1 interac-
tion with Ena/VASP proteins, as described in other cell types 
(Moeller et al., 2004; Tanoue and Takeichi, 2004), whereas the 
latter effect relies in part on decreased nuclear accumulation of 
β-catenin (this paper). Interestingly, we found that the Fat1IC 
interaction with and inhibition of β-catenin both appeared less 
Figure 10.  Cleavage, localization, and activity of Fat1 cytoplasmic 
  sequences in VSMC protein extracts. (A) Western analysis of A7r5 extracts 
transduced with IL2R-Fat1IC retrovirus. Total cellular protein was incubated 
at 37°C for 15 min with or without proteinase inhibitors (inhib). Both full-
length (FL) Fat1 and the fusion protein (IL2R-Fat1IC) are apparent with pro-
teinase inhibition; only a single band (Fat1IC*) of  50 kD is seen without 
inhibition. (B) Subcellular localization of the FLAG-tagged Fat1 cytoplasmic 
domain with (Fat14189–4587) or without (Fat14201–4587) the putative NLS in 
transfected A7r5 cells. Anti-FLAG immunoﬂ  uorescence and DAPI nuclear 
stains are shown. (C) Effect of the NLS on Fat1IC-mediated inhibition of 
β-catenin activation of the cyclin D1 promoter. Luciferase activity was 
  assessed 24 h after transfection of A7r5 cells with the indicated expression 
constructs and the cyclin D1 promoter reporter. Data show the means ± SEM. 
*, P < 0.01 vs. activity with β-catenin alone.FAT1 AND VASCULAR REMODELING • HOU ET AL. 427
robust than that observed with classical cadherin sequences 
(Figs. 7 and 9), suggesting that Fat1 may be less effi  cient than 
the classical cadherins at sequestering β-catenin. Fat1 induction 
after injury and by growth factors contrasts with the expression 
pattern of other cadherins found in VSMCs. Together, these ob-
servations suggest that Fat1 may guide VSMC migration while 
remaining relatively permissive of growth in settings when 
VSMC proliferation is necessary for vascular repair. Drosophila 
Ftl is thought to use its exceptionally large extracellular domain 
to promote epithelial cell separation during formation of tubular 
organs in embryogenesis (Castillejo-Lopez et al., 2004); we 
speculate that mammalian Fat1, by virtue of its similar struc-
ture, may expedite circumferential distribution of VSMCs 
around the injured artery. Altogether, it is tempting to speculate 
that Fat1 limits VSMC proliferation while providing directional 
migration cues important during vascular remodeling, provid-
ing an integrative function that may oppose the formation of 
hyperproliferative cellular clusters. Finally, though expression 
of Fat1 in human vascular disease has not yet been evaluated, it 
is possible that loss of Fat1-mediated negative regulation could 
contribute to VSMC hyperplastic syndromes such as restenosis, 
transplant arteriopathy, or vein graft disease.
Materials and methods
Rat carotid artery balloon injury
All procedures were in accordance with institutional guidelines. The rat ca-
rotid artery balloon injury model was implemented as described previously 
(Sibinga et al., 1997). In brief, male Sprague-Dawley rats (20 in total, 
Zivic-Miller) weighing 350–400 g were anesthetized with 40 mg/kg 
ketamine and 5 mg/kg xylazine. The left common carotid artery was de-
nuded of endothelium and stretched by three passages of a 2F embolectomy 
catheter according to standard protocols. At 3, 7, and 14 d after injury, 
animals were reanesthetized and killed, and carotid arteries were har-
vested and snap-frozen in liquid nitrogen for RNA and protein extraction, 
or ﬁ  xed with 4% PFA and processed for parafﬁ  n embedding for immuno-
histochemical analysis.
qPCR
A cDNA fragment identiﬁ   ed in differential mRNA display analysis of 
the rat carotid artery injury model (Sibinga et al., 1997) was cloned, se-
quenced, and subjected to BLAST analysis, which revealed homology of 
the sequence fragment with the 3′ end of the rat Fat1 ORF (GenBank/
EMBL/DDBJ accession no.NM_031819). Total RNA was extracted from 
vascular tissues by homogenization in TRIzol (Invitrogen), treated with 
DNase I (1 U/μlPromega), and used for ﬁ   rst-strand cDNA synthesis. 
The mRNA levels were quantiﬁ  ed in triplicate by qPCR in the Mx3000P 
Real-Time PCR System with the Brilliant SYBR Green qPCR kit (Stratagene). 
Rat Fat1 speciﬁ  c primers for qPCR were 5′-C  C  C  C  T  T  C  C  A  A  C  T  C  T  C  C  C  T  C  A  -3′ 
(forward) and 5′-C  A  G  G  C  T  C  T  C  C  C  G  G  G  C  A  C  T  G  T  -3′ (reverse). PCR cycling 
conditions included 10 min at 95°C for 1 cycle followed by 45 cycles at 
95°C for 30 s, 60°C for 30 s, and 72°C for 60 s. Dissociation curve analy-
sis conﬁ  rmed that signals corresponded to unique amplicons. Expression 
levels were normalized by glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) mRNA levels for each sample, obtained from parallel assays and 
analyzed using the comparative ∆∆Ct method (Bustin, 2000).
Western analysis
Fat1-speciﬁ  c antisera were raised in rabbits. A cDNA fragment encoding 
mouse Fat1 aa 4434–4587 was generated by PCR and cloned in frame 
with GST in the pGEX-2T plasmid. The resultant fusion protein was 
  expressed in bacteria, puriﬁ  ed by GST-Sepharose afﬁ  nity chromatography 
(GE Healthcare), and used as an immunogen in a standard rabbit injection 
protocol (Cocalico Labs). Fat1-speciﬁ  c antiserum was puriﬁ  ed by afﬁ  nity 
chromatography performed sequentially on a GST column and a GST-Fat1 
column. Antiserum speciﬁ  city was evaluated by Western analysis of GST-Fat1 
fusion protein and whole cell lysates from RASMCs (1:5,000   dilution). 
Other mouse antibodies used were anti-β-catenin (1:100; Santa Cruz 
  Biotechnology, Inc.), anti-cyclin D1 (1:100; NeoMarkers), anti-FLAG M2 
(1:5,000; Sigma-Aldrich), and anti-c-myc (1:250).
For protein analyses, cells or vascular tissue samples were homo-
genized and extracted in RIPA buffer with or without protease inhibitors. 
Whole cell lysate (30 μg) was separated by electrophoresis through 3–8% 
Novex Tris-acetate or 4–12% Bis-Tris polyacrylamide gels (Invitrogen) and 
transferred to Immobilon-P membrane (Millipore). After blocking in TBST 
(Tris pH 8.0, NaCl 150 mmol/L, and 0.1% Tween 20) plus 4% (wt/vol) 
nonfat milk, blots were incubated overnight at 4°C with primary anti-
bodies. The blots were then incubated with HRP-conjugated secondary 
  antibody and activity was visualized by ECL (GE Healthcare). Equivalent 
protein loading was evaluated with anti-α-tubulin (1:500; NeoMarkers), 
anti-lamin A/C (1:100; Santa Cruz Biotechnology, Inc.) or anti-actin 
(1:100, Santa Cruz Biotechnology, Inc.) antibodies.
Immunohistochemistry
Rat carotid arterial sections (5 μm) were incubated overnight with anti-Fat1 
antiserum (1:2,000), washed extensively, and incubated with a 1:500 di-
lution of secondary antibody (biotinylated goat anti–rabbit IgG, Dako-
Cytomation). Slides were incubated with avidin and biotinylated HRP, 
developed with a peroxidase substrate solution (DakoCytomation), and 
counterstained with hematoxylin (Fisher Schientiﬁ  c). Speciﬁ  city of staining 
was conﬁ  rmed by omission of the primary antibody. PCNA staining was 
performed with anti-PCNA (1:100; LabVision), alkaline phosphatase–
  conjugated goat anti–mouse secondary antibody (1:200), and visualiza-
tion with BM Purple substrate (Roche). Images were obtained using a 
microscope (Eclipse E600; Nikon), 40×/NA 0.75 Plan objective, and 
Coolpix 5400 camera (Nikon).
Cell culture
Primary culture RASMCs were prepared as described previously (Sibinga 
et al., 1997) and maintained in DME (Invitrogen) containing 10% FBS 
  (HyClone), 100 U/ml penicillin, 100 μg/ml streptomycin, and 10 mmol/L 
Hepes (pH 7.4; Sigma-Aldrich). RASMCs were passaged every 3 to 5 d, 
and used between 4 and 8 passages from harvest. Primary culture 
MASMCs were harvested from the aortas of 12-wk-old male Friend virus B 
mice by enzymatic dissociation, evaluated by immunocytochemical analy-
sis by using α-smooth muscle actin antibody (1:400, Clone 1A4; 
  NeoMarkers), and maintained in DME containing 10% FBS, 100 U/ml 
penicillin, and 100 μg/ml streptomycin. MASMCs were passaged every 
2 to 4 d, and used between 4 and 8 passages from harvest. The A7r5 em-
bryonic RASMC, 3T3, and 293T cell lines (American Tissue Type Collection) 
were cultured in DME containing 10% FBS. ATII was obtained from Sigma-
Aldrich, and bFGF and PDGF-BB from Collaborative Biomedical. In stimu-
lation experiments, the cells were made quiescent by incubation in medium 
containing 0.4% horse serum for 72 h before addition of the FBS or growth 
factor. Control cultures received an equivalent amount of vehicle. Whole 
cellular protein was extracted at designed time points.
RNAi
The mouse Fat1 siRNA templates were comprised of 19-bp sense se-
quences derived from GenBank/EMBL/DDBJ accession no. AJ250768 
(position 4881, 5′-G  G  A  C  C  G  A  A  G  T  C  A  C  C  A  A  G  T  A  -3′; position 5126, 
5′-G  C  G  A  C  G  C  A  T  T  T  A  A  C  A  T  T  A  A  -3′; position 6432, 5′-G  C  A  T  G  A  C  A  C  T  T  T  A  A-
A  T  A  A  A  -3′; position 7296; 5′-G  T  C  T  G  G  C  A  A  T  G  A  T  C  A  T  A  A  A  -3′) followed by 
a 9-bp loop sequence, a 19-bp antisense sequence, and a T7 promoter 
  sequence. Control siRNAs included scrambled (G  T  A  A  C  C  A  T  A  A  A  C  A  G  G-
C  A  T  T  ) and mismatched (underlined) (G  T  C  T  G  A  T  A  A  T  G  C  G  C  A  T  A  A  A  ) deriva-
tives of the 7296 sequence, and an unrelated siRNA based on the Renilla 
luciferase sequence. siRNA was transcribed in vitro using the T7-MEGAshort-
script kit (Ambion), and transfected with X-tremeGENE Reagent (Roche) 
  according to manufacturer’s recommendations. Fat1 knockdown efﬁ  ciency 
was assessed by Western analysis.
cDNA constructs
The mouse Fat1IC cDNA was generated by RT-PCR with primers 
  containing HindIII and XbaI sites (underlined) to facilitate cloning: for-
ward 5′-AAGCTTC  T  C  T  G  C  C  G  G  A  A  G  A  T  G  A  T  C  A  G  T  C  G  G  -3′ and reverse 
5′-TCTAGAC  A  C  T  T  C  C  G  T  A  T  G  C  T  G  C  T  G  G  G  A  . The product was subcloned 
into the p3XFLAG-CMV-14 expression vector (Aldrich). The IL2R expres-
sion construct (a gift of S. LaFlamme, Albany Medical College, Albany, 
NY; LaFlamme et al., 1994) was used to construct a chimeric cDNA 
encoding the IL2R extracellular and transmembrane domains and the 
Fat1IC, with or without an in frame 3XFLAG tag (IL2R-Fat1IC-3XFLAG and 
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produced   using a similar strategy. The truncated FLAG-tagged Fat1IC 
constructs, Fat4189–4587 and Fat14201–4587, were generated by PCR from 
the IL2R-Fat1IC-3XFLAG template using forward primers 5’-CCATGGg  c  c-
t  c  t  g  c  c  g  g  a  a  g  a  t  g  a  t  c  a  g  t  -3’and 5’-C  C  A  T  G  G  G  C  C  A  G  G  C  T  G  A  A  C  C  T  G  A  A  G  A-
C  A  A  A  C  -3’ and the CMV24 reverse primer; the resulting fragments were 
cloned into pcDNA3.1v5 (Invitrogen). The FLAG-tagged N-cadherin and 
Myc-tagged β-catenin constructs were gifts from R. Hazan (Albert Einstein 
College of Medicine, Bronx, NY) and R. Kemler (Max Planck Institute 
of Immunobiology, Freiburg, Germany), respectively. All constructs were 
conﬁ  rmed by sequencing.
Retrovirus preparation and transduction
The retrovirus system we used is based on the IRES-GFP-RV constructs de-
veloped by K. Murphy (Washington University, St. Louis, MO) and Phoenix 
ecotropic packing cells provided by G. Nolan (Stanford University, Stan-
ford, CA). The IL2R-Fat1IC cDNA was inserted upstream of the encephalo-
myocarditis virus internal ribosomal entry sequence (IRES) and green 
ﬂ  uorescent protein (GFP) ORF in the GFP-RV vector. A7r5 cells, MASMCs, 
or RASMCs (5 × 10
5) were infected with virus-containing supernatant in 
the presence of 8 μg/ml polybrene. Control cells transduced with virus 
encoding GFP alone or IL2R and GFP were generated in parallel, and 
FACS analysis of retroviral transduced cell lines indicated similar levels of 
GFP expression.
Cell migration assays
Cell migration was assessed by (1) scratch wounding of monolayers and 
(2) with Transwell 24-well cell culture inserts with 8-μm pores (Costar). For 
the former, MASMCs transfected with control or Fat1-speciﬁ  c siRNA were 
grown to conﬂ   uence, and monolayers were denuded similarly using a 
1,000-μl pipette tip. Photomicrographs of the same ﬁ  elds were obtained 
sequentially at 24 and 30 h after injury using a microscope (TMS; Nikon), 
Plan 4×/NA 0.13 DL objective, and camera (model 5400; Coolpix), and 
cellular progress was quantitated by planimetry of the denuded area and 
converted to distance migrated using NIH Image 1.63 software. For Tran-
swell assays, quiescent cells were harvested, counted, and added (5 × 
10
4/well) to the insert. Culture medium containing 10% FBS as chemotactic 
agent was added to the lower chamber. After 4 h, nonmigrating cells were 
removed from upper ﬁ  lter surfaces and the ﬁ  lter was washed, ﬁ  xed, and 
stained. We then photographed six randomly selected 200× ﬁ  elds and 
counted cells that had migrated to the underside of the ﬁ  lter.
Cell proliferation assays
Cell number was evaluated with the CyQUANT Assay (Molecular Probes). 
Cells (2 × 10
4 per well) were plated in 6-well plates in DMEM containing 
2% FBS, medium was replaced every other day, and at each time point 
triplicate wells were washed with PBS and frozen at −80°C. Net sample 
ﬂ  uorescence was determined on a Victor 2 plate reader (Wallac) and enu-
merated by reference to a standard curve. For the BrdU incorporation as-
say, cells plated on chamber slides (Becton Dickinson) were serum starved 
(0.4% horse serum) for 48 h and then stimulated with 10% FBS. 10 μM 
BrdU (Sigma-Aldrich) was added to cells for 6 h before harvest at 24 h. 
Cells were washed in PBS, ﬁ  xed in 4% PFA, treated with HCl, and stained 
sequentially with anti-BrdU antibody (1:200; Abcam) and AlexaFluor 
555–conjugated secondary antibody (1:2,000; Molecular Probes). Cells 
were counterstained with DAPI (Molecular Probes). Signals were visualized 
by ﬂ  uorescence microscopy, and the numbers of BrdU-positive and total 
nuclei per ﬁ  eld calculated.
Immunocytochemistry
Cells were plated on chamber slides 24 h before staining, and then 
washed with PBS, ﬁ  xed with PFA, blocked with 3% normal goat serum, and 
incubated with anti-β-catenin (1:100) and anti-Fat1 (1:1,000) antibodies. 
Speciﬁ  c staining was identiﬁ  ed with goat anti–mouse and chicken anti–
rabbit IgG (AlexaFluors, Molecular Probes). Expression of FLAG-tagged 
proteins was detected using FITC-conjugated anti-FLAG M2 antibody 
(8 μg/ml, Sigma-Aldrich). After counterstaining with DAPI, samples were 
mounted (Supermount medium; Biogenex) on glass slides and signals were 
visualized using an inverted ﬂ  uorescent microscope (model IX70; Olympus) 
equipped with 20×/NA 0.4 and 40×/NA 0.6 LWD objectives and stan-
dard ﬂ  uorescent ﬁ  lter sets, a CCD camera (SensiCam ; Cooke), and IPLab 
software (Scanalytics). Subsequent image processing was performed using 
Photoshop 7.0 and Illustrator 10.0 (Adobe Systems). Routine control ex-
periments included omission of the primary antibodies. For Wnt pathway 
activation, cells were treated with LiCl (20 mmol/L) for 6–12 h, and then 
stained with anti-β-catenin antibody and DAPI nuclear stain.
Co-immunoprecipitation
Deletions within the Fat1IC portion of the IL2R-Fat1IC-3XFLAG construct were 
engineered using the vector XbaI site and introducing NheI restriction sites 
(QuikChange mutagenesis; Stratagene) in frame at the following positions 
in the mouse Fat1 aa sequence: 4187, 4244, 4395, and 4497. The se-
quences between selected pairs of restriction sites were excised, plasmids 
recircularized, and constructs conﬁ  rmed by sequencing. Plasmids were in-
troduced into 293T cells using Lipofectamine 2000 (Invitrogen). Whole cell 
lysates were harvested 24 h after transfection in lysis buffer containing 
50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40, 0.1% 
sodium deoxycholate, 1 mM Na3VO4, 1 mM NaF, with protease inhibitors. 
Myc-tagged β-catenin was immunoprecipitated by incubating 400 μg of 
precleared lysate with 2 μg of c-Myc antibody for 2 h at 4°C, followed by 
incubation with protein G–Agarose (Invitrogen) at 4°C overnight. For 
  immunoprecipitation of endogenous proteins, RASMC whole cell lysates 
were precleared and then incubated with anti-Fat1 antiserum, anti-
β-catenin antibody, or normal rabbit or mouse IgG for 2 h at 4°C, followed 
by incubation with protein G–Agarose overnight. The beads were washed 
and immune complexes recovered by boiling in sample buffer. Fat1 and 
β-catenin were detected by Western analysis, as described above.
Cell fractionation
Membrane, cytoplasmic, and nuclear fractions were prepared using the 
Compartment Protein Extraction Kit (Chemicon International, Inc.) accord-
ing to the manufacturer’s instructions. Fractionation and loading of proteins 
was evaluated by Western analysis with anti-lamin A/C antibody (Santa 
Cruz Biotechnology, Inc.).
Analysis of reporter gene activation
A7r5 cells growing in DMEM supplemented with 10% FBS were trans-
fected transiently using Lipofectamine 2000 with β-catenin, IL2R-Fat1IC, 
Fat14189–4587, Fat14201–4587, or control expression constructs, along with the 
TCF wild-type (Topﬂ  ash) and mutated control (Fopﬂ  ash) luciferase reporter 
plasmids (Upstate Biotechnology), or cyclin D1 promoter luciferase reporter 
(a gift from R. Müller, Philipps-Universität, Marburg, Germany; Herber 
et al., 1994). MASMCs were transfected by Amaxa electroporation accord
-
ing to the manufacturer’s instructions. The total amount of transfected DNA 
was kept constant. Cell lysates were harvested 24 h after transfection, and 
luciferase activity was determined using the Glo-lysis buffer system 
  (Promega) and the Victor 2 plate reader. Luciferase activities were normalized 
to protein levels for each well. The data shown represent transfections re-
peated at least three times each.
Statistical analysis
Experiments were repeated at least three times. Data are presented as 
mean ± SEM. Comparisons between two groups were analyzed by t test, 
and comparisons between three or more groups were assessed by analysis 
of variance (ANOVA) with a Bonferroni/Dunn post hoc test. Signiﬁ  cance 
was accepted for values of P < 0.05.
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